Humana price to free cash flow HUM
Market value divided by free cash flow over the last twelve months, since 2010.
- Today, Oct 23, 2026
- 26.0×
- 10-year median
- 13.6×
- Against its 10-year history
- 78th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 4.7× to 131×
- Peer median
- 7.0×
Humana's price to free cash flow is 26.0× as of Oct 23, 2026.
That is above its ten-year median of 13.6×, higher than on 78% of days in the last ten years.
Over that time it ranged from 4.7× in Sep 2023 to 131× in Aug 2019.
The median for 6 health insurers of a similar size is 7.0×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 26.0× | 14.3× | 69.2× |
| 2025 | 20.1× | 11.2× | 20.9× |
| 2024 | 13.3× | 8.9× | 14.9× |
| 2023 | 11.3× | 4.7× | 18.9× |
| 2022 | 7.7× | 7.6× | 61.7× |
| 2021 | 42.6× | 10.1× | 131× |
| 2020 | 10.9× | 6.7× | 13.3× |
| 2019 | 13.1× | 11.2× | 131× |
| 2018 | 15.1× | 10.2× | 15.8× |
| 2017 | 7.3× | 6.6× | 7.3× |
| 2016 | 6.7× | 5.5× | 148× |
| 2015 | 153× | 21.4× | 371× |
| 2014 | 24.3× | 9.8× | 24.5× |
| 2013 | 10.6× | 7.0× | 10.7× |
| 2012 | 3.2× | 2.7× | 8.8× |
| 2011 | 4.0× | 3.7× | 7.2× |
| 2010 | 3.9× | 3.9× | 4.7× |
Against its peers
Companies in Medical - Healthcare Plans nearest Humana's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| HUMHumana | 26.0× |
| CNCCentene | 3.9× |
| CICigna | n/m |
| ELVElevance Health | 15.2× |
| CVSCVS Health | 10.2× |
| OSCROscar Health | 2.2× |
| UNHUnitedHealth | n/m |
| Peer median | 7.0× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Humana
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.